Vaccine adjuvant discovery program (VADP)
Active Definitive Contract Awarded Last action
- Contract number
- 75N93024C00022
- Awardee
-
University Of California, San Diego UEI UYTTZT6G9DT1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,726,546
Award facts
- Opportunity
-
- Vaccine adjuvant discovery program Pre-Solicitation · 75N93022R00022 · Posted Dec 5, 2022
- Contract value 56% obligated
-
- $5,726,546.00 Current, with exercised options
- $10,291,961.00 Potential, with all options
- Completion date 42% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 13 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- La Jolla, CA 92037, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $1,844,501 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $1,280,295 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,601,750 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $10,291,961 definitive contract to University of California, San Diego for the Vaccine Adjuvant Discovery Program (VADP) on September 30, 2024, under cost-no-fee pricing with ultimate completion on September 29, 2029. No set-aside applied.
The originating solicitation, posted as a pre-solicitation on December 5, 2022, seeks discovery and development of vaccine adjuvants to enhance immune response and vaccine efficacy. Place of performance is La Jolla, California.
UCSD self-performed substantially in FY2025, invoicing $1.4 million against a footprint of 3.4 FTEs with no reported subcontractor labor. The institution engaged specialized subcontractors for targeted technical scope: Research and Diagnostic Systems Inc. (December 24, 2024) for high-quality reagents, analytical kits, and precision diagnostics; Fisher Scientific Company L.L.C. (December 20, 2024) for Maybridge screening compounds; Cytek Biosciences Inc. (December 12, 2024) for flow cytometry products and services; and Covaris LLC (December 11, 2024) for advanced sample preparation tools utilizing proprietary focused acoustics technology. These subcontractors provide specialized scientific materials, instrumentation, and analytical capabilities supporting UCSD's core adjuvant discovery research mission. UCSD's role as a tax-exempt educational institution and 1862 Land Grant College positions this award within the institution's broader NIH-funded research portfolio spanning biomedical sciences and immunological research.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Research And Diagnostic Systems, Inc. | $54,950 | |
| Fisher Scientific Company L.L.C. | $31,346 | |
| Cytek Biosciences, Inc. | $103,698 | |
| Covaris, LLC | $53,026 |
Quick answers
Who was awarded contract 75N93024C00022?
75N93024C00022 was awarded to University Of California, San Diego by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2024.
How much is contract 75N93024C00022 worth?
The government has obligated $5,726,546 on 75N93024C00022. Its potential value, with all options, is $10,291,961.
Was contract 75N93024C00022 competed?
The extent of competition for 75N93024C00022 was full and open competition. The government received 13 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award